Trump Is Taking Hydroxychloroquine: Why Experts Say You Shouldn’t

  • President Trump reports that he’s taking hydroxychloroquine daily, even though there’s still little clinical evidence to show that it works.
  • The Food and Drug Administration (FDA) has also questioned its effectiveness and warned of potentially fatal side effects, such as irregular heart rhythms.
  • Hydroxychloroquine and chloroquine are both approved by the FDA to treat or prevent malaria and certain autoimmune conditions, such as lupus and rheumatoid arthritis — but they’re not approved to treat COVID-19.

All data and statistics are based on publicly available data at the time of publication. Some information may be out of date. 

FDA NOTICEThe FDATrusted Source have removed the Emergency Use Authorization (EUA) for hydroxychloroquine and chloroquine for the treatment of COVID-19. Based on a review of the latest research, the FDA determined that these drugs are not likely to be an effective treatment for COVID-19 and that the risks of using them for this purpose might outweigh any benefits.

On Monday, President Donald Trump claimed that he’s taking daily doses of hydroxychloroquine, a drug that he’s long promoted as a potential treatment for COVID-19.

So far, though, no clinical trials have shown that this drug, or the related chloroquine, work against COVID-19.

The Food and Drug Administration (FDA) has also questioned its effectiveness and warned of potentially fatal side effects, such as irregular heart rhythms.

Trump told reporters that he has been taking hydroxychloroquine daily, along with a zinc supplement “for about a week and a half now.”

He added that he had requested the drug from White House physician Dr. Sean Conley.

In a press release, Conley said that after reviewing the evidence for the use of hydroxychloroquine, “we concluded the potential benefit from treatment outweighed the relative risks.”

Hydroxychloroquine and chloroquine are both approved by the FDA to treat or prevent malaria and certain autoimmune conditions, such as lupus and rheumatoid arthritis.

They haven’t been approved as a COVID-19 treatment.

However, the FDA issued an emergency use authorizationTrusted Source in March for these drugs. This allows physicians to administer them to people with severe COVID-19.